Nasdaq 100 Stocks Performance Guide: Regeneron Pharmaceuticals Inc (REGN)
REGN has no dividends.
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $316.22 |
| End Date | Jul-26-2024 |
| End Price | $1,078.63 |
| # Prices | 121 |
| Min Date | Sep-30-2019 |
| Min Price | $277.40 |
| Max Date | Jul-26-2024 |
| Max Price | $1,078.63 |
| Total Return | 241.10% |
| Annualized Return | 12.94% |
| Current Value of $1,000 Purchase | $3,411 |
| Number Returns | 7,260 |
| Average Return | 42.50% |
| Number Profitable Returns | 5,494 |
| Percent Profitable Returns | 75.67% |
| Number Unprofitable Returns | 1,766 |
| Percent Unprofitable Returns | 24.33% |
| Profitable to Unprofitable Returns Ratio | 3.11 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $117,258,830,000 |
| Beta | 0.128 | Price to Sales | 7.57 |
| Earnings per Share | $33.9200 |
| PE Ratio | 31.37 |
| PE to Growth Ratio | 1.459 |
| Price to Book | 3.823 |
| PRICE DATA | |
| 52 Week High | $1106.16 |
| 52 Week Low | $726.11 |
| Analyst Target Price | $1104.34 |
| 50-Day Moving Average | $1029.57 |
| 200-Day Moving Average | $930.05 |
| FINANCIAL DATA | |
| Revenue per Share | $122.57 |
| Revenue | $13,100,100,000 |
| Profit Margin | 29.4% |
| Return on Equity | 15.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
REGN Compare Returns with S&P 500
REGN Trendline Chart
REGN Moving Average Chart
REGN Stock Return Map - See Patterns of Gains and Losses
REGN Stock Returns/Purchase Dates